SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer

Background: Taxanes are frontline chemotherapeutic drugs for patients with triple-negative breast cancer (TNBC); however, chemoresistance reduces their effectiveness. We hypothesized that the molecular profiling of tumor samples before and after neoadjuvant chemotherapy (NAC) would help identify gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xi-Yu, Jiang, Wang, Ma, Ding, Ge, Li-Ping, Yang, Yun-Song, Gou, Zong-Chao, Xu, Xiao-En, Shao, Zhi-Ming, Jiang, Yi-Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532662/
https://www.ncbi.nlm.nih.gov/pubmed/33042263
http://dx.doi.org/10.7150/thno.45207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532662/
https://www.ncbi.nlm.nih.gov/pubmed/33042263
http://dx.doi.org/10.7150/thno.45207

Ejemplares similares